Catalyst Wire Dossier Catalyst Wire Dossier

aripiprazole/escitalopram combination

aripiprazole and escitalopram · Otsuka Pharmaceutical Development & Commercialization, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for aripiprazole/escitalopram combination, covering 2021-10-20 to 2021-10-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) [Phase 3]

See pricing